Filing Flows › AtriCure (ATRC) › Q4 2025
AtriCure (ATRC) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 19, 2026
AtriCure (ATRC) reported revenue of $140M for the fourth quarter 2025 (Q4 2025), +13% from a year earlier and +5% from the quarter before. Operating margin was 1.8%, net earnings $1.8M (1.2% of revenue).
AtriCure, Q4 2025: revenue $140M (+13% year over year), operating margin 1.8%, net earnings $1.8M, operating cash flow $20.0M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $140M | +5% | +13% |
| Gross profit | $105M | +4% | +14% |
| Operating profit | $2.5M | 12× | — |
| Net earnings | $1.8M | — | — |
| Operating cash flow | $20.0M | -25% | +243% |
| Free cash flow | $18.4M | -24% | +486% |
What changed
Revenue was $140.5M in Q4 2025, up 13% year over year and up 5% from the previous quarter.
Gross margin was 75.0%, up 0.4 points from a year earlier. Operating profit was $2.5M, a 1.8% margin (up 13.5 points year over year). Operating expenses fell 4% while revenue rose 13%. Net earnings were $1.8M. The effective tax rate was 25.6%.
Operating cash flow was $20.0M (up 243% year over year), 1140% of net earnings. Non-cash charges added back $5.1M of depreciation and amortization and $11.3M of share-based compensation. Working capital and other items added $1.9M. Capital expenditures of $1.6M left free cash flow of $18.4M.
Questions
What was AtriCure's revenue in the fourth quarter 2025?
AtriCure (ATRC) reported revenue of $140M for the fourth quarter 2025 (Q4 2025), +13% from a year earlier and +5% from the quarter before.
Was AtriCure profitable in the fourth quarter 2025?
Operating profit was $2.5M (1.8% of revenue) and net earnings $1.8M.
Source: AtriCure 10-K on SEC EDGAR.